Influenza Surveillance Program

The molecular virology unit uses real time RT-PCR (reverse transcriptase-polymerase chain reaction) to detect novel influenza, as well as all seasonal strains of flu in clinical samples.  PHEL partners with the NJDOH Communicable Disease Service (CDS) to enhance influenza surveillance throughout the state.  A network of providers submits clinical samples to PHEL from patients with influenza-like illness.  Rapid molecular testing provides clinicians and epidemiologists at CDS the ability to quickly respond to new cases or clusters of disease.

Last Reviewed: 8/1/2022